Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)


Why precision medicine?


Cluster news


Mathieu Groussin receives ERC grant for innovative gut microbiome research

European Research Council funds research project at Kiel University to investigate the role of bacterial extracellular vesicles in gut ecology and health with two million euros.


group photo

DFG Research Unit "miTarget" at Kiel University enters second funding phase

The German Research Foundation (DFG) is funding the Research Unit 5042 "miTarget: The microbiome as a therapeutic target in chronic inflammatory bowel diseases" for a further four years.

Röhrchen mit Blut in einem Metallständer

Possible new biomarker for better detection of numerous inflammatory diseases

Increased consumption of tryptophan can indicate minimal residual inflammation in a variety of chronic inflammatory diseases.


Young Scientist Retreat 2024

Around 60 young researchers from the Cluster of Excellence PMI met on March 13 and 14, 2024 for a scientific exchange at the Maritim Seehotel on Timmendorfer Strand.